Tuesday, January 27 2026

Haleon Pakistan to invest $4.9mn in Panadol Liquid packaging expansion
Haleon Pakistan Limited, formerly known as GlaxoSmithKline, has approved an investment of £3.58 million (USD 4.9 million) to expand and modernise its Panadol Liquid packaging line, as part of efforts to boost production capacity and improve operational efficiency amid rising demand. The pharmaceutical disclosed the development in a notice to the Pakistan Stock Exchange (PSX) on Tuesday. “Haleon Pakistan Limited is pleased to announce its decision to invest £3.58 million in the expansion and modernisation of its Panadol Liquid packaging line,” read the notice.
Related news categories: business economic-indicators pharma psx stock-exchanges
Related symbols: HALEON (news stock)